Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) — Working Capital to Net Assets Ratio
Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) has a Working Capital to Net Assets ratio of -0.1% as of March 2026. Working capital of $-314.52K (current assets of $351.76K minus current liabilities of $666.28K) is measured against net assets of $491.56 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Drugs Made In America Acquisition II Cor (DMII) financial flexibility to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Drugs Made In America Acquisition II Corp. Ordinary Shares Working Capital to Net Assets (2024–2025)
This chart shows how Drugs Made In America Acquisition II Corp. Ordinary Shares's Working Capital to Net Assets ratio has evolved across 2 annual periods from 2024 to 2025. As of March 2026, the ratio stands at -0.1%, reflecting working capital of $-314.52K against net assets of $491.56 Million USD. See Drugs Made In America Acquisition II Cor liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Drugs Made In America Acquisition II Corp. Ordinary Shares (2024–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Drugs Made In America Acquisition II Corp. Ordinary Shares from 2024 to 2025, covering 2 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see DMII stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -0.1% | $-274.83K | $487.16 Million | $26.04K | $300.86K | ▼ -167.3 pp |
| 2024 | 167.2% | $-195.17K | $-116.72K | $59.62K | $254.78K | — |